Literature DB >> 25385994

Belliella kenyensis sp. nov., isolated from an alkaline lake.

Juliah Khayeli Akhwale1,2, Markus Göker1, Manfred Rohde3, Peter Schumann1, Hans-Peter Klenk4,1, Hamadi Iddi Boga5.   

Abstract

A red-pigmented, Gram-reaction-negative, aerobic bacterial strain, designated No.164(T), was isolated from sediment sample from the alkaline Lake Elmenteita located in the Kenyan Rift Valley. Results of 16S rRNA gene sequence analysis indicated that the isolate represented a member of the genus Belliella, with the highest sequence similarity (97 %) to Belliella pelovolcani DSM 46698(T). Optimal growth temperature was 30-35 °C, at pH 7.0-12.0 in the presence of 0-4 % (w/v) NaCl. Flexirubins were absent. The respiratory menaquinone (MK-7), predominant cellular fatty acids (iso-C15 : 0, anteiso-C15 : 0 and a mixture of C16 : 1ω7c and/or iso-C15 : 0 2-OH) and DNA G+C content (38.1 mol%) of strain No.164(T) were consistent with those of other members of the genus Belliella. The polar lipids consisted of phosphatidylethanolamine, eight unspecified lipids and one unspecified phospholipid. Several phenotypic characteristics can be used to differentiate this isolate from those of other species of the genus Belliella. The results of polyphasic analyses presented in this study indicated that this isolate should be classified as representing a novel species of the genus Belliella. The name Belliella kenyensis sp. nov. is therefore proposed; the type strain is strain No.164(T) ( = DSM 46651(T) = CECT 8551(T)).
© 2015 IUMS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25385994     DOI: 10.1099/ijs.0.066951-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  1 in total

1.  Comparative genomic analysis of eight novel haloalkaliphilic bacteriophages from Lake Elmenteita, Kenya.

Authors:  Juliah Khayeli Akhwale; Manfred Rohde; Christine Rohde; Boyke Bunk; Cathrin Spröer; Hans-Peter Klenk; Hamadi Iddi Boga; Johannes Wittmann
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.